Jennison Associates’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-159,434
Closed -$14.9M 588
2023
Q3
$14.9M Buy
159,434
+37,363
+31% +$3.5M 0.01% 339
2023
Q2
$10.9M Buy
122,071
+108,991
+833% +$9.73M 0.01% 372
2023
Q1
$1.4M Sell
13,080
-580
-4% -$62.2K ﹤0.01% 470
2022
Q4
$1.67M Sell
13,660
-499
-4% -$60.9K ﹤0.01% 451
2022
Q3
$1.46M Buy
+14,159
New +$1.46M ﹤0.01% 474